Improved insulin sensitivity may reduce hepatic lipogenesis and visceral fat accumulation
Nausea, vomiting, and appetite changes Mild to moderate nausea is the most common side effect
And the starting doses, while lower, are being injected into tissue that has not adapted to regular subcutaneous medication administration
CV risk profile subgroups To assess the effect of baseline CV risk profiles on outcomes, two separate subgroup analyses were performed: (1) for subjects who had experienced a prior MI or stroke compared with those who had not, and (2) for those with established CVD, defined as prior stroke, ischemic heart disease (including MI), peripheral arterial disease, 50% arterial stenosis in any artery, coronary revascularization (percutaneous coronary intervention or coronary artery bypass graft), or heart failure vs those with CV risk factors alone and no manifestations of CVD as defined above
Always confirm the mg/mL printed on your pharmacy label before drawing up
[PMID: 16124382] PubMed record related to this compound for laboratory literature review